The digital therapeutics explainer : How digital treatments could be a $9 billion opportunity by 2025

"A new class of medicine - digital therapeutics (DTx) - has emerged, offering a novel means of treating the swelling number of patients with chronic diseases and keeping associated costs down. Advertisement Digital therapeutics deliver evidence-based therapies via software - often in the form of consumer-facing mobile health apps - that replace or complement the existing treatment of a disease. They diverge from the broader digital health market in that..." Lire la suite